Financial Analyst Summary
Company Clarification Regarding NSE Query
Date of Communication: 20th June, 2026
Nature of Query: The National Stock Exchange of India Limited raised a query regarding a discrepancy in the XBRL filing of Financial Results submitted on May 25, 2026. The specific issue was that Earnings Per Share (EPS) was not mentioned in the XBRL filing.
Company's Clarification
Gujarat Themis Biosyn Limited clarified that the omission of EPS data was due to an inadvertent error during the XBRL format filing process. The company explicitly stated that:
- There is no change in the financial results that were approved by the Board of Directors and submitted to the Exchange.
- The omission is purely technical in nature.
- The omission does not impact the financial performance, profitability, or any other financial information disclosed by the Company.
Corrective Action
The company acknowledged the exchange's observation and stated it is submitting a revised/corrected XBRL filing that incorporates the required EPS details.
Sentiment & Topic Tags
Topics: Regulatory Response, Financial Results Clarification, Compliance, XBRL Filing